Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,422 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Fractional flow reserve use in coronary artery revascularization: A systematic review and meta-analysis.
Sanz Sánchez J, Farjat Pasos JI, Martinez Solé J, Hussain B, Kumar S, Garg M, Chiarito M, Teira Calderón A, Sorolla-Romero JA, Echavarria Pinto M, Shin ES, Diez Gil JL, Waksman R, van de Hoef TP, Garcia-Garcia HM. Sanz Sánchez J, et al. Among authors: waksman r. iScience. 2023 Jul 3;26(8):107245. doi: 10.1016/j.isci.2023.107245. eCollection 2023 Aug 18. iScience. 2023. PMID: 37520737 Free PMC article.
Serial 2-dimensional and 3-dimensional optical coherence tomography assessment of overhanging struts of drug-eluting absorbable metal scaffold: "DREAMS" for jailed side branch?
Muramatsu T, García-García HM, Serruys PW, Waksman R, Verheye S; BIOSOLVE-I Investigators. Muramatsu T, et al. Among authors: waksman r. JACC Cardiovasc Interv. 2014 May;7(5):575-6. doi: 10.1016/j.jcin.2013.07.022. JACC Cardiovasc Interv. 2014. PMID: 24852807 Free article. No abstract available.
Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial.
Haude M, Ince H, Abizaid A, Toelg R, Lemos PA, von Birgelen C, Christiansen EH, Wijns W, Neumann FJ, Kaiser C, Eeckhout E, Lim ST, Escaned J, Garcia-Garcia HM, Waksman R. Haude M, et al. Among authors: waksman r. Lancet. 2016 Jan 2;387(10013):31-9. doi: 10.1016/S0140-6736(15)00447-X. Epub 2015 Oct 12. Lancet. 2016. PMID: 26470647
One Good Friend Is Better Than Many.
Lee SY, Waksman R, Garcia-Garcia HM. Lee SY, et al. Among authors: waksman r. JACC Cardiovasc Imaging. 2016 Jul;9(7):902-903. doi: 10.1016/j.jcmg.2016.01.012. Epub 2016 Apr 13. JACC Cardiovasc Imaging. 2016. PMID: 27085443 Free article. No abstract available.
Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial.
Haude M, Ince H, Abizaid A, Toelg R, Lemos PA, von Birgelen C, Christiansen EH, Wijns W, Neumann FJ, Kaiser C, Eeckhout E, Lim ST, Escaned J, Onuma Y, Garcia-Garcia HM, Waksman R. Haude M, et al. Among authors: waksman r. Eur Heart J. 2016 Sep 14;37(35):2701-9. doi: 10.1093/eurheartj/ehw196. Epub 2016 May 17. Eur Heart J. 2016. PMID: 27190094 Free PMC article. Clinical Trial.
1,422 results